	- Oral contraceptives
	- Intrauterine device (IUD)
	- Implants
	- Hormonal contraception
	- Barrier method
	- Abstinence
	- Sterilization
	- Male condoms
	- Female condoms
	- Diaphragm
	- Spermicide
	- Withdrawal
	- Other
	- Postmenopausal women not taking estrogen replacement therapy
	- Women who have undergone tubal ligation
	- Men whose partners are surgically sterile or postmenopausal
	- Men who agree to practice abstinence or use a condom throughout the duration of the study and for 6 months after stopping the treatment
•	Patients with a history of hypersensitivity to any component of the study drug
•	Patients with a history of severe hypersensitivity reactions to any monoclonal antibody
•	Patients with a history of autoimmune disease
•	Patients with a history of idiopathic thrombocytopenia purpura or thrombotic throm